Literature DB >> 18405969

Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma.

Katalin Kádár1, Margit Kovács, István Karádi, Béla Melegh, Zsuzsa Pocsai, Gábor Mikala, Attila Tordai, Agnes Szilágyi, Róza Adány, George Füst, Judit Várkonyi.   

Abstract

Allelic distribution of -308 G>A (TNF 1/2) polymorphism of the TNF-alpha, and the +252 A>G promoter polymorphism of the LT-alpha gene, the 1267 A>G polymorphism of the HSP70-2 gene as well as the -429 T>C promoter polymorphism of the RAGE gene were tested in 94 MM cases and 141 controls. Significantly less MM patients than controls carried the TNF2 allele (p=0.018) and the TNF2-LTA 252G haplotype (p=0.025). The difference was, however, restricted to the females, as well as the relatively young (<69 years) subjects. By contrast, we did not find differences with the other SNPs tested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18405969     DOI: 10.1016/j.leukres.2008.03.001

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  12 in total

1.  Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.

Authors:  Kyoung-Mu Lee; Dalsu Baris; Yawei Zhang; H Dean Hosgood; Idan Menashe; Meredith Yeager; Shelia Hoar Zahm; Sophia S Wang; Mark P Purdue; Stephen Chanock; Tongzhang Zheng; Nathaniel Rothman; Qing Lan
Journal:  Am J Hematol       Date:  2010-08       Impact factor: 10.047

2.  HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Maria Gazouli; Alexandra Tsigginou; Constantine Dimitrakakis; Irene Papaspyrou; Evaggelos Eleutherakis-Papaiakovou; Dimosthenis Chrysikos; George Theodoropoulos; George C Zografos; Aris Antsaklis; Athanassios-Meletios Dimopoulos; Christos A Papadimitriou
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

3.  TNF-β +252 A>G polymorphism and susceptibility to cancer.

Authors:  Lin Yang; Rennan Feng; Guiyou Liu; Mingzhi Liao; Liangcai Zhang; Wenbo Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-03       Impact factor: 4.553

4.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

5.  TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms.

Authors:  H Rauert; T Stühmer; R Bargou; H Wajant; D Siegmund
Journal:  Cell Death Dis       Date:  2011-08-18       Impact factor: 8.469

6.  Genetic Variations of Tumor Necrosis Factor -α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients.

Authors:  Hajar Nasiri; Safar Farajnia; Azim Rezamand; Ali Akbar Movassaghpour; Heydar Ali Esmaeili; Amir Monfaredan; Naser Mobarra; Nasser Rahimifar; Leyla Sahebi; Majid Farshdousti Hagh
Journal:  Iran J Basic Med Sci       Date:  2013-09       Impact factor: 2.699

7.  Heat shock protein 70 gene polymorphisms and cancer risk: a meta-analysis.

Authors:  Lei He; Tao Deng; He-sheng Luo
Journal:  ScientificWorldJournal       Date:  2014-07-20

8.  Interaction between IL-6 and TNF-α genotypes associated with bacteremia in multiple myeloma patients submitted to autologous stem cell transplantation (ASCT).

Authors:  Fernanda M B Trigo; Marcelo R Luizon; Hélio S Dutra; Angelo Maiolino; Márcio Nucci; Belinda P Simões
Journal:  Leuk Res Rep       Date:  2014-09-01

9.  Genetically lowered concentrations of circulating sRAGE might cause an increased risk of cancer: Meta-analysis using Mendelian randomization.

Authors:  Qingxian Huang; Jia Mi; Xizhen Wang; Fang Liu; Dan Wang; Dong Yan; Bin Wang; Shuping Zhang; Geng Tian
Journal:  J Int Med Res       Date:  2016-02-08       Impact factor: 1.671

Review 10.  Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

Authors:  Caterina Musolino; Alessandro Allegra; Vanessa Innao; Andrea Gaetano Allegra; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Mediators Inflamm       Date:  2017-09-26       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.